Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 4/20 | 0.45 |
| ▸ | CYP4A11 | Q02928 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
| ▸ | RXRG | P48443 | 1/20 | 0.37 |
| ▸ | PDE9A | O76083 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ATR | Q13535 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27287833 | 0.89 | CYP4F2 (0.42) | CYP4F2CYP4A11LMNAALDH1A1POLB | |
| SCHEMBL31625850 | 0.89 | CYP4F2 (0.42) | CYP4F2CYP4A11LMNAALDH1A1POLB | |
| SCHEMBL31111161 | 0.84 | CYP4F2 (0.40) | CYP4F2CYP4A11LMNAALDH1A1POLB | |
| SCHEMBL21196060 | 0.84 | CYP4F2 (0.45) | CYP4F2CYP4A11LMNAALDH1A1POLB | |
| SCHEMBL31111006 | 0.80 | CYP4F2 (0.46) | CYP4F2CYP4A11LMNAALDH1A1POLB | |
| SCHEMBL29344187 | 0.79 | CYP4F2 (0.41) | CYP4F2CYP4A11LMNAALDH1A1POLB | |
| SCHEMBL27287826 | 0.78 | CYP4F2 (0.38) | CYP4F2CYP4A11LMNAALDH1A1POLB | |
| SCHEMBL30840550 | 0.78 | CYP4F2 (0.38) | CYP4F2CYP4A11LMNAALDH1A1POLB | |
| SCHEMBL31179123 | 0.78 | CYP4F2 (0.44) | CYP4F2CYP4A11LMNAALDH1A1POLB | |
| SCHEMBL28673628 | 0.78 | CYP4F2 (0.49) | CYP4F2CYP4A11LMNAALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673141-A1 | NBD1 MODULATORS AND METHODS OF USING THE SAME | Sionna Therapeutics Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024182751-A1 | NBD1 MODULATORS AND METHODS OF USING THE SAME | SIONNA THERAPEUTICS INC. (US) | 2024-09-06 | — | — | WO | disclosed |